HK

Hema Karunanithi

Active Director Director DIN 07174709
DIN 07174709 First appointment Jun 2015 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2015
Shareholding value •••• Premium profile

About Hema Karunanithi

Data last updated:

Hema Karunanithi is a Director at Drharans Medicare Private Limited (since 2015). The company operates in Healthcare. Drharans Medicare Private Limited reported revenue of ₹52.2 Lakh (FY 2025).

DIN 07174709
Primary Designation Director
Industry Healthcare
First Appointment 30 Jun 2015
Oldest Company Age 11 yrs
Largest company Drharans Medicare Private Limited · ₹52.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drharans Medicare Private Limited U74999TN2015PTC101189
Director30 Jun 20152015₹52.2 Lakh (FY 2025)Active

Board colleagues of Hema Karunanithi

Directorship timeline

Open interactive timeline →
Drharans Medicare Private Limited
Premium access

Shareholding and investment profile for Hema Karunanithi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hema Karunanithi

Hema Karunanithi currently holds 1 directorship: Drharans Medicare Private Limited (Director, since 30 Jun 2015, revenue ₹52.2 Lakh (FY 2025)).

Hema Karunanithi was first appointed on 30 Jun 2015 as Director at Drharans Medicare Private Limited.

The current boards of Hema Karunanithi's companies include Hariharan Sathananthan Vythilingam (Drharans Medicare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available